Dana Zakalik, M.D. is the Corporate Director of the Nancy and James Grosfeld Cancer Genetics Center at Corewell Health William Beaumont University Hospital  and  Professor in the Oakland University William Beaumont Medical School. She is Board Certified in Internal Medicine and Oncology.

Dr. Zakalik completed her undergraduate and Medical School studies at the University of Michigan, Ann Arbor, where she went on to do her residency and Chief Residency in Internal Medicine. She completed a Fellowship in Hematology and Oncology at the University of California, San Francisco, where she became faculty and conducted NIH funded research in the area of gene regulation in cancer development. Dr. Zakalik was instrumental in developing a Cancer Genetics Program at Beaumont at a time when the understanding of Cancer Genetics was coming into the forefront of Oncology. Since then she has grown the program to become a national leader in Cancer Genetics and Precision Oncology 

Dr. Zakalik  is a core faculty member in the Hematology/Oncology Fellowship Program, served in the Medical School Admissions committee, and teaches in the Cancer Genetics curriculum . She serves on the Board of the Michigan Cancer Consortium where she has chaired the Cancer Genomics Committee and the Cancer Prevention Committee. She recently served as co-chair of the ASCO Guideline committee on management of hereditary breast cancer. 

Dana Zakalik, M.D.

Professor, Medicine and Oncology

Oakland University William Beaumont School of Medicine

Corporate Director, Nancy and James Grosfeld Cancer Genetics Program

Lead, Precision Oncology Committee

Corewell Health William Beaumont University Hospital